Ashley Larrimore 3/4/24 Ashley Larrimore 3/4/24 GENAI WILL CHANGE THE FOCUS OF ADVANCED ANALYTIC HIRING Read More Ashley Larrimore 1/16/24 Ashley Larrimore 1/16/24 THE HIDDEN RISKS AND COSTS OF MANUAL AI IN PHARMA Read More Ashley Larrimore 11/14/23 Ashley Larrimore 11/14/23 TOP 3 REASONS PHARMA SHOULD USE VELOCITY FOR GENAI Read More Ashley Larrimore 10/11/23 Ashley Larrimore 10/11/23 VELOCITY: A GAME CHANGER FOR COMMERCIAL PHARMA’S COMPETITIVE EDGE Read More Guest User 9/21/23 Guest User 9/21/23 MAXIMIZE THE ROI ON YOUR DATA SCIENCE INVESTMENTS THROUGH ANALYTIC OPERATIONS Read More Ashley Larrimore 4/27/23 Ashley Larrimore 4/27/23 THE TOP 4 REASONS EXECUTIVES NEED TO TAKE ANALYTIC OPERATIONS SERIOUSLY Read More Ashley Larrimore 2/14/23 Ashley Larrimore 2/14/23 WHY IS COMMERCIAL PHARMA DEMANDING MORE FREQUENT ANALYTICS? Read More Ashley Larrimore 12/12/22 Ashley Larrimore 12/12/22 WHAT ARE THE KEY INPUTS TO OMNICHANNEL CUSTOMER ENGAGEMENT ANALYTICS? Read More Ashley Larrimore 12/8/22 Ashley Larrimore 12/8/22 SENTIER ANALYTICS JOINS THE MATTER COMMUNITY Read More Ashley Larrimore 11/3/22 Ashley Larrimore 11/3/22 IS ARTIFICIAL INTELLIGENCE THE BOTTLENECK TO OMNICHANNEL ENGAGEMENT? Read More Ashley Larrimore 11/2/22 Ashley Larrimore 11/2/22 DR. CONSTANTINE PAPAGEORGIOU JOINS SENTIER AS CHIEF DATA SCIENTIST Read More Ashley Larrimore 9/14/22 Ashley Larrimore 9/14/22 The Benefits of an Analytic Product - Democratizing AI Insights Read More Ashley Larrimore 6/29/22 Ashley Larrimore 6/29/22 THE AI DEPOT Read More Ashley Larrimore 5/23/22 Ashley Larrimore 5/23/22 THE CALL PLAN IS DEAD! Read More Ashley Larrimore 4/20/22 Ashley Larrimore 4/20/22 WHAT IS THE BEST DEFENSE AGAINST DIRTY DATA? INCORPORATE BUSINESS KNOWLEDGE INTO YOUR DATA INTEGRATION PRACTICES Read More Ashley Larrimore 3/14/22 Ashley Larrimore 3/14/22 WHAT’S IN A NAME? THAT WHICH WE CALL OPERATIONS BY ANY OTHER NAME WOULD SMELL AS SWEET… Read More Ashley Larrimore 2/17/22 Ashley Larrimore 2/17/22 DEEP CONSIDERATIONS FOR MOVING FROM MULTICHANNEL TO OMNICHANNEL IN PHARMA Read More Ashley Larrimore 1/10/22 Ashley Larrimore 1/10/22 HIGH VELOCITY AI - A GAME CHANGER FOR 2022 Read More Ashley Larrimore 12/1/21 Ashley Larrimore 12/1/21 AN ANALYTIC PLAN: THE KEY TO SUCCESS Read More Ashley Larrimore 11/1/21 Ashley Larrimore 11/1/21 5 INSIGHTS THAT WILL GUIDE YOUR 2022 DATA AND ANALYTICS PLANNING Read More Older Posts
Ashley Larrimore 3/4/24 Ashley Larrimore 3/4/24 GENAI WILL CHANGE THE FOCUS OF ADVANCED ANALYTIC HIRING Read More
Ashley Larrimore 1/16/24 Ashley Larrimore 1/16/24 THE HIDDEN RISKS AND COSTS OF MANUAL AI IN PHARMA Read More
Ashley Larrimore 11/14/23 Ashley Larrimore 11/14/23 TOP 3 REASONS PHARMA SHOULD USE VELOCITY FOR GENAI Read More
Ashley Larrimore 10/11/23 Ashley Larrimore 10/11/23 VELOCITY: A GAME CHANGER FOR COMMERCIAL PHARMA’S COMPETITIVE EDGE Read More
Guest User 9/21/23 Guest User 9/21/23 MAXIMIZE THE ROI ON YOUR DATA SCIENCE INVESTMENTS THROUGH ANALYTIC OPERATIONS Read More
Ashley Larrimore 4/27/23 Ashley Larrimore 4/27/23 THE TOP 4 REASONS EXECUTIVES NEED TO TAKE ANALYTIC OPERATIONS SERIOUSLY Read More
Ashley Larrimore 2/14/23 Ashley Larrimore 2/14/23 WHY IS COMMERCIAL PHARMA DEMANDING MORE FREQUENT ANALYTICS? Read More
Ashley Larrimore 12/12/22 Ashley Larrimore 12/12/22 WHAT ARE THE KEY INPUTS TO OMNICHANNEL CUSTOMER ENGAGEMENT ANALYTICS? Read More
Ashley Larrimore 12/8/22 Ashley Larrimore 12/8/22 SENTIER ANALYTICS JOINS THE MATTER COMMUNITY Read More
Ashley Larrimore 11/3/22 Ashley Larrimore 11/3/22 IS ARTIFICIAL INTELLIGENCE THE BOTTLENECK TO OMNICHANNEL ENGAGEMENT? Read More
Ashley Larrimore 11/2/22 Ashley Larrimore 11/2/22 DR. CONSTANTINE PAPAGEORGIOU JOINS SENTIER AS CHIEF DATA SCIENTIST Read More
Ashley Larrimore 9/14/22 Ashley Larrimore 9/14/22 The Benefits of an Analytic Product - Democratizing AI Insights Read More
Ashley Larrimore 4/20/22 Ashley Larrimore 4/20/22 WHAT IS THE BEST DEFENSE AGAINST DIRTY DATA? INCORPORATE BUSINESS KNOWLEDGE INTO YOUR DATA INTEGRATION PRACTICES Read More
Ashley Larrimore 3/14/22 Ashley Larrimore 3/14/22 WHAT’S IN A NAME? THAT WHICH WE CALL OPERATIONS BY ANY OTHER NAME WOULD SMELL AS SWEET… Read More
Ashley Larrimore 2/17/22 Ashley Larrimore 2/17/22 DEEP CONSIDERATIONS FOR MOVING FROM MULTICHANNEL TO OMNICHANNEL IN PHARMA Read More
Ashley Larrimore 1/10/22 Ashley Larrimore 1/10/22 HIGH VELOCITY AI - A GAME CHANGER FOR 2022 Read More
Ashley Larrimore 11/1/21 Ashley Larrimore 11/1/21 5 INSIGHTS THAT WILL GUIDE YOUR 2022 DATA AND ANALYTICS PLANNING Read More